A detailed history of Vickerman Investment Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Vickerman Investment Advisors, Inc. holds 61,636 shares of PFE stock, worth $1.6 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
61,636
Previous 61,198 0.72%
Holding current value
$1.6 Million
Previous $1.71 Million 4.15%
% of portfolio
0.54%
Previous 0.57%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$27.7 - $31.39 $12,132 - $13,748
438 Added 0.72%
61,636 $1.78 Million
Q2 2024

Aug 09, 2024

SELL
$25.26 - $29.6 $16,444 - $19,269
-651 Reduced 1.05%
61,198 $1.71 Million
Q1 2024

May 09, 2024

SELL
$25.89 - $29.73 $30,032 - $34,486
-1,160 Reduced 1.84%
61,849 $1.72 Million
Q4 2023

Jan 09, 2024

SELL
$26.13 - $33.94 $127,932 - $166,170
-4,896 Reduced 7.21%
63,009 $1.81 Million
Q3 2023

Nov 02, 2023

BUY
$32.09 - $37.51 $4,139 - $4,838
129 Added 0.19%
67,905 $2.25 Million
Q2 2023

Jul 31, 2023

BUY
$36.12 - $41.79 $162,612 - $188,138
4,502 Added 7.12%
67,776 $2.49 Million
Q1 2023

May 04, 2023

BUY
$39.39 - $51.28 $114,940 - $149,635
2,918 Added 4.83%
63,274 $2.58 Million
Q4 2022

Feb 09, 2023

BUY
$41.75 - $54.5 $74,690 - $97,500
1,789 Added 3.05%
60,356 $3.09 Million
Q3 2022

Nov 08, 2022

BUY
$43.76 - $53.42 $81,699 - $99,735
1,867 Added 3.29%
58,567 $2.56 Million
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $151,222 - $179,302
3,250 Added 6.08%
56,700 $2.97 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $207,201 - $256,749
4,529 Added 9.26%
53,450 $2.62 Million
Q4 2021

Jan 28, 2022

SELL
$41.32 - $61.25 $400,184 - $593,206
-9,685 Reduced 16.53%
48,921 $2.89 Million
Q3 2021

Dec 13, 2021

BUY
$39.25 - $50.42 $2.3 Million - $2.95 Million
58,606 New
58,606 $2.52 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $146B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Vickerman Investment Advisors, Inc. Portfolio

Follow Vickerman Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vickerman Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vickerman Investment Advisors, Inc. with notifications on news.